IceCure Medical Ltd — Cash Flow (NASDAQ:ICCM) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -12.61 M-14.29 M-12.52 M-12.56 M—-14.57 M -30.64 M Cash from investing activities 3.79 M-891 K-713 K446 K—-36 K — Cash from financing activities 30.89 M13.58 M83 K9.19 M—15.83 M — Free cash flow -13.14 M-15.18 M-13 M-12.63 M—-14.61 M -30.64 M

뉴스

IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript

아이스큐어 메디컬, 2026년 1월 임시 주주총회 예정

IceCure Medical schedules special shareholder meeting for January 2026

Nvidia, Target, TJX, and more set to report earnings Wednesday

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates

아이스큐어 메디컬, 냉동절제 연구에서 생존율 개선 발표 후 주가 급등

IceCure Medical stock jumps after cryoablation study shows improved survival rates

Freezing Cancer With IceCure: ProSense Cryoablation System Receives FDA Marketing Authorization For Early-Stage Breast Cancer Treatment - Icecure Medical (NASDAQ:ICCM)

아이스큐어 메디컬(ICCM) 목표 주가, H.C. Wainwright서 2.50달러로 상향

IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright

IceCure Medical Ltd (ICCM) U.S. FD&A's MarketingAuthorizationforProSenseCryoablation Call